BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 27597727)

  • 1. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
    Khanam H; Ali A; Asif M; Shamsuzzaman
    Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
    Kanemaru K
    Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
    Scannevin RH
    Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
    Fatima MT; Islam Z; Ahmad E; Salahuddin P
    Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein aggregation and neurodegenerative diseases: From theory to therapy.
    Kumar V; Sami N; Kashav T; Islam A; Ahmad F; Hassan MI
    Eur J Med Chem; 2016 Nov; 124():1105-1120. PubMed ID: 27486076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein aggregation, misfolding and consequential human neurodegenerative diseases.
    Sami N; Rahman S; Kumar V; Zaidi S; Islam A; Ali S; Ahmad F; Hassan MI
    Int J Neurosci; 2017 Nov; 127(11):1047-1057. PubMed ID: 28110595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
    Trippier PC; Jansen Labby K; Hawker DD; Mataka JJ; Silverman RB
    J Med Chem; 2013 Apr; 56(8):3121-47. PubMed ID: 23458846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer and its applications in neurodegenerative diseases.
    Qu J; Yu S; Zheng Y; Zheng Y; Yang H; Zhang J
    Cell Mol Life Sci; 2017 Feb; 74(4):683-695. PubMed ID: 27563707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
    Naeem A; Fazili NA
    Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding.
    Ho L; Pasinetti GM
    Expert Rev Proteomics; 2010 Aug; 7(4):579-89. PubMed ID: 20653511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases.
    Sonninen TM; Goldsteins G; Laham-Karam N; Koistinaho J; Lehtonen Š
    Cells; 2020 Sep; 9(10):. PubMed ID: 32998318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid aptamers for neurodegenerative diseases.
    Bouvier-Müller A; Ducongé F
    Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecules that target protein misfolding.
    Gavrin LK; Denny RA; Saiah E
    J Med Chem; 2012 Dec; 55(24):10823-43. PubMed ID: 23075044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion-like spread of protein aggregates in neurodegeneration.
    Polymenidou M; Cleveland DW
    J Exp Med; 2012 May; 209(5):889-93. PubMed ID: 22566400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
    Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
    Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.